Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1

Phu Hoang Anh Nguyen, Shuetsu Fukushi, Souichi Yamada, Shizuko Harada, Tomoki Yoshikawa, Hitomi Kinoshita, Madoka Kawahara, Takuma Ogawa, Hideki Ebihara, Meng Ling Moi, Masayuki Saijo

Research output: Contribution to journalArticlepeer-review

Abstract

IMPORTANCE: Zoonotic infection of humans with herpes B virus (BV) causes severe neurological diseases. Acyclovir (ACV) and ganciclovir (GCV), most frequently used as anti-herpes drugs, are recommended for prophylaxis and therapy in human BV infection. In this study, we examined the property of BV thymidine kinase (TK) against anti-herpes drugs using a recombinant herpes simplex virus type 1 (HSV-1) carrying BV TK gene. We found that HSV-1 carrying BV TK was similarly sensitive to GCV as HSV-1 carrying varicella zoster virus TK. In addition, we demonstrated that BV TK was not mutated in the GCV- and ACV-resistant HSV-1 carrying BV TK, suggesting that ACV- or GCV-resistant BV might be rare during treatment with these antiviral drugs. These data can provide a new insight into the properties of BV TK in terms of the development of drug resistance.

Original languageEnglish (US)
Pages (from-to)e0309123
JournalMicrobiology Spectrum
Volume12
Issue number1
DOIs
StatePublished - Jan 11 2024

Keywords

  • B virus
  • DNA polymerase
  • acyclovir
  • acyclovir resistant
  • ganciclovir
  • ganciclovir resistant
  • herpes simplex virus 1
  • thymidine kinases

ASJC Scopus subject areas

  • Physiology
  • Ecology
  • General Immunology and Microbiology
  • Genetics
  • Microbiology (medical)
  • Cell Biology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1'. Together they form a unique fingerprint.

Cite this